bmy-28100 is a new oral cephalosporin which had in vitro activity superior to that of cephalexin and cefaclor against staphylococci , beta-hemolytic streptococcal species , and streptococcus pneumoniae .
C0007716
cephalexin
C0007537
cefaclor